Modified phages: Novel antimicrobial agents to combat infectious diseases
- 1 November 2011
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 29 (6) , 732-738
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Bacteriophage-Resistant Staphylococcus aureus Mutant Confers Broad Immunity against Staphylococcal Infection in MicePLOS ONE, 2010
- Bacteriophages and cancerArchives of Microbiology, 2010
- Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage TherapyThe Journal of Infectious Diseases, 2010
- A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coliVirology, 2009
- Kinetics of Phage-Mediated Biocontrol of BacteriaFoodborne Pathogens and Disease, 2009
- Phage-Mediated Intergeneric Transfer of Toxin GenesScience, 2009
- Bacteriophage Therapy and the Mutant Selection WindowAntimicrobial Agents and Chemotherapy, 2008
- Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentallyClinical Microbiology and Infection, 2006
- Bacteriophage P100 for control of Listeria monocytogenes in foods: Genome sequence, bioinformatic analyses, oral toxicity study, and applicationRegulatory Toxicology and Pharmacology, 2005
- Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growthBiochimica et Biophysica Acta (BBA) - General Subjects, 2000